Detalhe da pesquisa
1.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180954
2.
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents.
Anticancer Drugs
; 33(1): e43-e51, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387593
3.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735386
4.
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.
Future Oncol
; 15(10): 1115-1123, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30887825
5.
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
BMC Cancer
; 17(1): 493, 2017 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724419
6.
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.
Future Oncol
; 10(10): 1741-50, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641206
7.
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression.
Transl Oncol
; 41: 101869, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290249
8.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410103
9.
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
JAMA Netw Open
; 6(11): e2345185, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010650
10.
Incidence of grade 3-4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis.
Expert Opin Drug Metab Toxicol
; 18(3): 235-240, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485878
11.
Safety and Efficacy of a First-Line Chemotherapy Tailored by G8 Score in Elderly Metastatic or Locally Advanced Gastric and Gastro-Esophageal Cancer Patients: A Real-World Analysis.
Geriatrics (Basel)
; 7(5)2022 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286210
12.
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study.
Eur Urol
; 81(3): 274-282, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34602312
13.
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Front Oncol
; 12: 955501, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36212433
14.
The leader peptide of a human rec. MnSOD as molecular carrier which delivers high amounts of Cisplatin into tumor cells inducing a fast apoptosis in vitro.
Int J Cancer
; 128(2): 453-9, 2011 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20309937
15.
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study.
Diagnostics (Basel)
; 11(6)2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071518
16.
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Eur J Cancer
; 155: 56-63, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358777
17.
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
Ther Adv Urol
; 13: 17562872211054302, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707691
18.
Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide.
Clin Genitourin Cancer
; 19(5): e286-e298, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958297
19.
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Ther Adv Med Oncol
; 13: 17588359211019642, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046089
20.
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer.
Eur J Cancer
; 140: 140-146, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091718